Data News > Orthofix Medical Facing Class Action Lawsuits from Multiple Law Firms
- Investors who suffered losses in excess of $100,000 have until October 21, 2024, to file lead plaintiff applications in a securities class action lawsuit against Orthofix Medical, Inc.
- Several law firms, including Kahn Swick & Foti, Levi & Korsinsky, Pomerantz Law Firm, the Schall Law Firm, and Bronstein, Gewirtz & Grossman, have announced class action lawsuits against Orthofix Medical Inc.
- The lawsuits allege violations of federal securities laws related to the purchase of Orthofix securities during the Class Period from October 11, 2022, to September 12, 2023.
- Investors are encouraged to contact the respective law firms for more information on potential recovery and lead plaintiff deadlines.
- The lead plaintiff deadline for the class action lawsuits is set for October 21, 2024.
Multiple law firms, including Kahn Swick & Foti, Levi & Korsinsky, Pomerantz Law Firm, the Schall Law Firm, and Bronstein, Gewirtz & Grossman, have initiated class action lawsuits against Orthofix Medical Inc., prompting an opportunity for investors to seek potential recovery for losses incurred during a specific timeframe.
Investors who suffered losses exceeding $100,000 have until October 21, 2024, to file lead plaintiff applications in the securities class action lawsuit against Orthofix Medical, Inc. The Class Period for the lawsuit spans from October 11, 2022, to September 12, 2023, during which investors are alleged to have purchased the company's shares under questionable circumstances.
The lawsuits by various law firms accuse Orthofix Medical Inc. of violations of federal securities laws, specifically related to investors who purchased the company's securities between October 11, 2022, and September 12, 2023. These allegations have led to a legal battle that aims to recover damages on behalf of all persons and entities affected during the defined Class Period.
Investors interested in learning more about the pending class action lawsuits and the potential for recovery under federal securities laws are advised to reach out to the respective law firms involved in the litigation. Each firm, including Kahn Swick & Foti, Levi & Korsinsky, Pomerantz Law Firm, the Schall Law Firm, and Bronstein, Gewirtz & Grossman, offers information on how investors can participate in seeking justice for any losses incurred during the Class Period.
The lead plaintiff deadline for the class action lawsuits filed against Orthofix Medical Inc. is October 21, 2024, providing a limited window of opportunity for investors to take action and potentially recover any damages suffered due to alleged violations of federal securities laws. Contacting the law firms involved can offer more detailed insights into the lawsuits and the steps investors can take to become actively involved in seeking redress for their losses.
For more information:
Up/Down Rally Price Distribution Analyst Recommendations Earning Price Impact Analysis Seasonality
Orthofix Medical Facing Class Action Lawsuits from Multiple Law Firms
By KlickAnalytics Data Insights | September 5, 2024 08:06PM ET
Key Points
- Investors who suffered losses in excess of $100,000 have until October 21, 2024, to file lead plaintiff applications in a securities class action lawsuit against Orthofix Medical, Inc.
- Several law firms, including Kahn Swick & Foti, Levi & Korsinsky, Pomerantz Law Firm, the Schall Law Firm, and Bronstein, Gewirtz & Grossman, have announced class action lawsuits against Orthofix Medical Inc.
- The lawsuits allege violations of federal securities laws related to the purchase of Orthofix securities during the Class Period from October 11, 2022, to September 12, 2023.
- Investors are encouraged to contact the respective law firms for more information on potential recovery and lead plaintiff deadlines.
- The lead plaintiff deadline for the class action lawsuits is set for October 21, 2024.
Multiple law firms, including Kahn Swick & Foti, Levi & Korsinsky, Pomerantz Law Firm, the Schall Law Firm, and Bronstein, Gewirtz & Grossman, have initiated class action lawsuits against Orthofix Medical Inc., prompting an opportunity for investors to seek potential recovery for losses incurred during a specific timeframe.
Investors who suffered losses exceeding $100,000 have until October 21, 2024, to file lead plaintiff applications in the securities class action lawsuit against Orthofix Medical, Inc. The Class Period for the lawsuit spans from October 11, 2022, to September 12, 2023, during which investors are alleged to have purchased the company's shares under questionable circumstances.
The lawsuits by various law firms accuse Orthofix Medical Inc. of violations of federal securities laws, specifically related to investors who purchased the company's securities between October 11, 2022, and September 12, 2023. These allegations have led to a legal battle that aims to recover damages on behalf of all persons and entities affected during the defined Class Period.
Investors interested in learning more about the pending class action lawsuits and the potential for recovery under federal securities laws are advised to reach out to the respective law firms involved in the litigation. Each firm, including Kahn Swick & Foti, Levi & Korsinsky, Pomerantz Law Firm, the Schall Law Firm, and Bronstein, Gewirtz & Grossman, offers information on how investors can participate in seeking justice for any losses incurred during the Class Period.
The lead plaintiff deadline for the class action lawsuits filed against Orthofix Medical Inc. is October 21, 2024, providing a limited window of opportunity for investors to take action and potentially recover any damages suffered due to alleged violations of federal securities laws. Contacting the law firms involved can offer more detailed insights into the lawsuits and the steps investors can take to become actively involved in seeking redress for their losses.
For more information:
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.